NCT06173687

Brief Summary

This early feasibility study aims to collect pilot data on impedance measurements in real-world environments and to collect real-world and difficult listening situations and the factors impacting this, reflecting situations the subjects encounter during their daily life outside of the clinic. Improving the monitoring of both aspects may lead to improvements in monitoring and personalising the fitting to optimise hearing outcomes for persons with a cochlear implant.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
3 countries

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 19, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

January 29, 2024

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 24, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

December 3, 2025

Completed
Last Updated

December 3, 2025

Status Verified

November 1, 2025

Enrollment Period

9 months

First QC Date

October 19, 2023

Results QC Date

November 20, 2025

Last Update Submit

November 20, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Impedance Measurements

    Median of the standard deviation in total electrode impedance (measured in kOhm, averaged across 22 electrode contacts) between days for 8 weeks.

    8 Weeks

Study Arms (1)

All participants

EXPERIMENTAL
Device: The impedance measurement task using the Mobile Research App (MRA)

Interventions

Characterisation of impedance and real-world monitoring of hearing difficulty in range of listening environments.

All participants

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18 years or older (no upper age limit).
  • Implanted with CIC4-based implant with a Contour Advance, Slim Straight or Slim Modiolar electrode array with at least 6 months experience.
  • Candidate is a fluent speaker in the language used to assess speech perception performance, as determined by the investigator.
  • Willing and able to provide written informed consent.

You may not qualify if:

  • Score below 3 on the screening subset of questions from the Mobile Device Proficiency Questionnaire (digital literacy check).
  • A failed ECE1 or ECE2 (i.e. flagged, open circuit or short circuit)
  • Additional health factors, known to the investigator, that would prevent or restrict participation in the evaluations, including significant visual impairment and/or dexterity issues.
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
  • Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling.
  • Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation.
  • Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Cochlear Macquarie

Sydney, New South Wales, 2109, Australia

Location

HEARnet

Carlton, Victoria, 3052, Australia

Location

ENT Department, Sint-Augutinus Antwerp

Wilrijk, Antwerp, 2610, Belgium

Location

Cochlear Bone Anchored Solutions AB (CBAS)

Mölnlycke, Västergötland, 43533, Sweden

Location

MeSH Terms

Conditions

Hearing Loss

Condition Hierarchy (Ancestors)

Hearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
PRS Specialist
Organization
Cochlear Limited

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2023

First Posted

December 18, 2023

Study Start

January 29, 2024

Primary Completion

October 24, 2024

Study Completion

October 24, 2024

Last Updated

December 3, 2025

Results First Posted

December 3, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Cochlear do not have an approved platform for public sharing of IPD collected in this study. Data may be provided to individual researchers on request.

Locations